Enter your terms above and click the 'Search' button.

Showing articles 0 to 12 of 12 Filter Applied: melanoma,malignant (Click to remove) Case Records of MGH NEJM 281:836, 1969 Metastatic Carcinoma to CNS., , 1969 Severe Neurological Toxicity of Immune Checkpoint Inhibitors: Growing Spectrum Ann Neurol 87:659-669, Dubey, D.,et al, 2020 Incidence and Outcome of Neurologic Immune-Related Adverse Events Associated with Immune Checkpoint Inhibitors in Patients with Melanoma Neurol 101:e2472-e2482, Pepys,J.,et al, 2023 Myasthenia Gravis Following Dabrafenib and Trametinib for Metastatic Melanoma Neurol 94:322-323, Zaloum, A.,et al, 2020 Severe Neurological Toxicity of Immune Checkpoint Inhibitors: Growing Spectrum Ann Neurol 87:659-669, Dubey, D.,et al, 2020 Pembrolizumab-Induced Myasthenia Gravis Neurol 91:e1365-e1367, Algaeed, M.,et al, 2018 Inflammatory Demyelinating Polyneuropathy Versus Leptomeningeal Disease Following Ipilimumab J Immunother Cancer 6:11, Cafuir, L.,et al, 2018 Neurological, Respiratory, Musculoskeletal, Cardiac and Ocular Side-Effects of Anti-PD-1 Therapy Eur J Cancer 60:210-225, Zimmer, L.,et al, 2016 Neurological Immune-Related Adverse Events of Ipilimumab Pract Neurol 13:278-280, Bot, I.,et al, 2013 Intracerebral and Subarachnoid Hemorrhage in Patients with Cancer Neurol 74:494-501, Navi,B.B.,et al, 2010 Neurology and the Skin JNNP 66:417-430, Hurko,O.&Provost,T.T., 1999 Infiltration of the Leptomeninges by Systemic Cancer:a Clinical & Pathologic Study Arch Neurol 30:122, Olson,M.E.,et al, 1974 Showing articles 0 to 12 of 12